Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

11.4K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.4K
Amyloid Fibrils03:03

Amyloid Fibrils

6.1K
6.1K
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

148
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
148

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody-mediated rejection of transplanted kidney associated with anti-Jka alloantibodies: An interesting case report with review of literature.

Asian journal of transfusion science·2026
Same author

Histone methyltransferase G9a crosstalks with H3K36 histone methyltransferases NSD3 and SETD2 to mediate gene activation.

Frontiers in cell and developmental biology·2026
Same author

A Rare Case of Traumatic Internal Mammary Artery Pseudoaneurysm Causing Hemopericardium: Endovascular Management and Literature Review.

Acta medica Lituanica·2026
Same author

Corrigendum to "Randomized Controlled Trial on the Efficacy of Reduced-Dose Cyclical Corticosteroids and Cyclophosphamide in Primary Membranous Nephropathy" [<i>Kidney International Reports</i> Volume 10, Issue 11, November 2025, Pages 3785-3795].

Kidney international reports·2026
Same author

BET bromodomain inhibition: a potential therapeutic avenue in MEF2D-HNRNPUL1-rearranged B-cell acute lymphoblastic leukaemia.

Leukemia & lymphoma·2026
Same author

Neuroprotective Effect of Palmatine Against Anti-Epileptic Drug Induced Autism in Wistar Rat Pups.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2025

Related Experiment Video

Updated: Dec 6, 2025

Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

14.0K

Rare, Yet Emerging Cause of Graft Dysfunction-ALECT 2 Amyloidosis.

Kulwant Singh1, Jasmine Sethi1, Rajan Duggal2

  • 1Division of Nephrology, Grecian Hospital, Mohali, Punjab, India.

Indian Journal of Nephrology
|October 5, 2020
PubMed
Summary

Leukocyte cell-derived chemotaxin 2 (LECT2) amyloidosis is a rare condition affecting kidneys and liver. This case highlights a LECT2 renal amyloidosis in a transplant recipient, emphasizing the need for further research into effective therapies.

Keywords:
ALECT2 amyloidgraft dysfunctionrenal transplant

More Related Videos

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

17.4K
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

16.6K

Related Experiment Videos

Last Updated: Dec 6, 2025

Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

14.0K
Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

17.4K
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

16.6K

Area of Science:

  • Nephrology
  • Pathology
  • Transplantation

Background:

  • Amyloidosis involves abnormal protein aggregate deposition, with AL protein being most common.
  • Leukocyte cell-derived chemotaxin 2 (LECT2) amyloidosis is a recently identified subtype, primarily affecting the kidneys and liver.
  • This condition lacks established effective therapeutic strategies.

Observation:

  • A kidney transplant recipient presented with declining graft function and proteinuria.
  • Diagnostic evaluation revealed amyloid deposition consistent with LECT2 amyloidosis in the kidney graft.
  • This represents the first documented case of LECT2 amyloidosis in a transplant recipient from Northern India.

Findings:

  • The case confirms ALECT2 amyloidosis can affect kidney allografts.
  • The clinical presentation included progressive graft dysfunction and subnephrotic proteinuria.
  • No specific therapeutic interventions for ALECT2 amyloidosis are currently established.

Implications:

  • This case expands the known clinical spectrum and geographic distribution of ALECT2 amyloidosis.
  • Understanding ALECT2 amyloidosis in transplant recipients is crucial for graft surveillance and management.
  • Further research is needed to develop targeted therapies for this rare amyloidosis subtype.